Skip to main content
OpenTrials
Completed

NCT Number: NCT00658190

Internet-Based Cervical Cytology Screening Program

The purpose of this study is to assess whether a system that couples automated screening of Pap Tests with transmission of machine selected digital images, and review by cytologists at a remote location, performs to a clinically effective standard of accuracy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–64 year

Sex eligibility

Female

Study type

Observational

Primary location

Walter Reed Army Medical Center, Washington D.C., District of Columbia, United States

Loading trial locations.

About this study

This clinical study uses the automated screening capabilities of the FocalPoint Primary Screening System (BD) for gynecologic cytology specimens (Pap tests) to allow for automated field of view (FOV) selection, digital image capture, and subsequent Internet-based transmission to a custom designed computer-based image reading station. The system utilizes liquid-based cytology preparations (ThinPrep, SurePath). In such a system, no skilled cytology human resources are necessary at the scanning site, and all expertise can be centralized. Pilot studies showed that the task was feasible to a clinically relevant standard of care. Phase 1 trials on preselected and seeded specimens confirmed this clinical standard. The phase 2 trials extend the concept to a prospectively enrolled population of patients from 2 sites (Walter Reed, Mass General) thereby testing the concept in a population of normal disease prevalence. The final phase 3 will be a larger study with intended use design, siting a screening device at the 121st Army Hospital in Korea and interpreting the specimen images in the US. In addition to the reading of the specimens, the system is designed to give immediate "loop closing" results back to each specimen's originating point immediate upon completion of the test.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female presenting to clinic for a Pap test for any reason

Exclusion criteria

  • Pregnant
  • Prisoners
  • Mentally unable to provide informed consent

Treatment and study plan

Primary outcomes

  1. Cervical cytology abnormal cases

    Time frame: At enrollment

    Identification of abnormalities compared to the initial interpretation

Sponsors and collaborators

Lead sponsor

Massachusetts General Hospital

Other

Collaborators

  • U.S. Army Medical Research and Development Command
  • Walter Reed Army Medical Center

Registry information

Acronym: IBCCSP

Important dates

Study start
2003
Primary completion
2012
Study completion
2013
First posted
Apr 14, 2008
Registry last updated
Apr 7, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.